MIF and myopathy: A prior study established a biomarker risk score utilizing circulating MIF levels and five additional proteins to prognosticate sarcopenia in patients with chronic heart failure and chronic obstructive pulmonary disease that highlights the potential role of MIF in certain myopathies (Qaisar et al., 2021).